Hennion & Walsh Asset Management »

Lexeo Therapeutics shares owned by Hennion & Walsh Asset Management

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Hennion & Walsh Asset Management from 13F filings

Historical chart of Hennion & Walsh Asset Management investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Hennion & Walsh Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Hennion & Walsh Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 266k 4.66

More positions owned by Hennion & Walsh Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Wisdomtree Tr Dynamic Intl Eqt (DDWM)
Vanguard Index Fds Value Etf (VTV)
Columbia Etf Tr Ii Em Core Ex Etf (XCEM)
Blackrock Muniyield Quality Fund (MQY)
Proshares Tr S&p 500 High Etf (ISPY)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Janus Detroit Str Tr Hendersn Cap Etf (JSML)
Ishares Tr Invt Grad Sy Etf (IGEB)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Applied Materials (AMAT)
Alphabet Cap Stk Cl A (GOOGL)
Lam Research Corp Com New (LRCX)
Micron Technology (MU)
Nuveen Insd Dividend Advantage (NVG)

View all positions for Hennion & Walsh Asset Management

Top funds holding Lexeo Therapeutics

Paradigm Biocapital Advisors
BlackRock
Affinity Asset Advisors
RA Capital Management
Henderson Group
Vestal Point Capital
Frazier Life Sciences Management
Citadel Advisors
OrbiMed Advisors
State Street Corporation
Vanguard Capital Management
Woodline Partners
Goldman Sachs Group
venBio Select Advisor
Point72 Asset Management

View all funds holding Lexeo Therapeutics